BioSyent Inc. (BIOYF)
OTCMKTS: BIOYF · Delayed Price · USD
7.49
0.00 (0.00%)
Jun 28, 2024, 1:40 PM EDT - Market closed
BioSyent Market Cap
BioSyent has a market cap or net worth of $88.36 million as of July 3, 2024. Its market cap has increased by 36.41% in one year.
Market Cap
88.36M
Enterprise Value
71.85M
1-Year Change
36.41%
Ranking
n/a
Category
Stock Price
$7.49
Market Cap Chart
Since July 5, 2019, BioSyent's market cap has increased from $67.54M to $88.36M, an increase of 30.82%. That is a compound annual growth rate of 5.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 28, 2024 | 87.37M | 6.92% |
| Dec 29, 2023 | 81.72M | 29.65% |
| Dec 30, 2022 | 63.03M | -24.61% |
| Dec 31, 2021 | 83.61M | 5.28% |
| Dec 31, 2020 | 79.41M | 18.14% |
| Dec 31, 2019 | 67.22M | -0.48% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 847.83B |
| Novo Nordisk | 620.82B |
| UnitedHealth Group | 451.21B |
| Johnson & Johnson | 349.57B |
| Merck & Co. | 318.52B |
| AbbVie | 290.37B |
| AstraZeneca | 237.80B |
| Novartis AG | 208.80B |